"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 7 | 7 |
| 1997 | 0 | 10 | 10 |
| 1998 | 0 | 14 | 14 |
| 1999 | 0 | 24 | 24 |
| 2000 | 0 | 22 | 22 |
| 2001 | 0 | 29 | 29 |
| 2002 | 0 | 24 | 24 |
| 2003 | 0 | 47 | 47 |
| 2004 | 0 | 31 | 31 |
| 2005 | 0 | 41 | 41 |
| 2006 | 0 | 41 | 41 |
| 2007 | 0 | 52 | 52 |
| 2008 | 0 | 42 | 42 |
| 2009 | 4 | 47 | 51 |
| 2010 | 4 | 53 | 57 |
| 2011 | 9 | 57 | 66 |
| 2012 | 4 | 64 | 68 |
| 2013 | 4 | 60 | 64 |
| 2014 | 6 | 61 | 67 |
| 2015 | 11 | 83 | 94 |
| 2016 | 6 | 72 | 78 |
| 2017 | 7 | 86 | 93 |
| 2018 | 7 | 88 | 95 |
| 2019 | 10 | 104 | 114 |
| 2020 | 6 | 80 | 86 |
| 2021 | 7 | 64 | 71 |
| 2022 | 0 | 37 | 37 |
| 2023 | 0 | 38 | 38 |
| 2024 | 19 | 35 | 54 |
| 2025 | 6 | 54 | 60 |
| 2026 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
POD24 is a novel determinant of prognosis in patients with Waldenstr?m macroglobulinemia. Blood Adv. 2026 Apr 14; 10(7):2322-2327.
-
Children and Young People With First Relapse or Progression of Upfront Metastatic Rhabdomyosarcoma: An Analysis of Clinical Features and Outcomes From the INternational Soft Tissue saRcoma ConsorTium (INSTRuCT). Cancer Med. 2026 Mar; 15(3):e71524.
-
Quantifying pathological progression from single-cell transcriptomic data with scPSS. Genome Res. 2026 Feb 03; 36(2):375-386.
-
Aberrant cellular communities underlying disease heterogeneity in chronic obstructive pulmonary disease. Nat Genet. 2026 Feb; 58(2):376-391.
-
Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes. J Clin Endocrinol Metab. 2026 Jan 21; 111(2):e493-e499.
-
Prognostic Significance of Peripheral Blood Monocyte Count Among a National Cohort of Veterans with Pulmonary Fibrosis. Ann Am Thorac Soc. 2026 Jan 01; 23(1):56-62.
-
Deletion of Megalin in Kidney Tubular Epithelium Up-Regulates TGF?1 Signaling, Aggravates Ischemia/Reperfusion Kidney Injury, and Accelerates the Progression to Chronic Kidney Disease. Am J Pathol. 2026 Mar; 196(3):657-668.
-
Initiation of a global consortium to study the progression of age-related macular degeneration: RIMR AMD consortium report # 1. Graefes Arch Clin Exp Ophthalmol. 2026 Apr; 264(4):935-943.
-
Bracing Outcomes and Risk of Curve Progression in Adolescents with Idiopathic Scoliosis and Autism Spectrum Disorder. J Bone Joint Surg Am. 2026 Apr 01; 108(7):499-506.
-
Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer. Cell Rep Med. 2025 Dec 16; 6(12):102474.